ESSILORLUXOTTICA 1/2/O.N. (ESLC) - Total Assets
Based on the latest financial reports, ESSILORLUXOTTICA 1/2/O.N. (ESLC) holds total assets worth €65.06 Billion EUR (≈ $76.06 Billion USD) as of June 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
ESSILORLUXOTTICA 1/2/O.N. - Total Assets Trend (2021–2025)
This chart illustrates how ESSILORLUXOTTICA 1/2/O.N.'s total assets have evolved over time, based on quarterly financial data. Also see ESSILORLUXOTTICA 1/2/O.N. market cap and net worth for the company's overall valuation and market capitalisation.
ESSILORLUXOTTICA 1/2/O.N. - Asset Composition Analysis
Current Asset Composition (December 2025)
ESSILORLUXOTTICA 1/2/O.N.'s total assets of €65.06 Billion consist of 18.8% current assets and 81.2% non-current assets. Review ESLC current and long-term liabilities to assess the company's total debt and financial obligations.
| Asset Category | Amount (EUR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 5.6% |
| Accounts Receivable | €3.64 Billion | 5.7% |
| Inventory | €3.54 Billion | 5.5% |
| Property, Plant & Equipment | €0.00 | 0.0% |
| Intangible Assets | €9.75 Billion | 15.3% |
| Goodwill | €31.01 Billion | 48.5% |
Asset Composition Trend (2021–2025)
This chart illustrates how ESSILORLUXOTTICA 1/2/O.N.'s asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. See latest ESSILORLUXOTTICA 1/2/O.N. stock price today for real-time trading data and today's change.
Key Asset Composition Facts
- Current vs. Non-Current Assets: ESSILORLUXOTTICA 1/2/O.N.'s current assets represent 18.8% of total assets in 2025, an increase from 15.6% in 2021.
- Cash Position: Cash and equivalents constituted 5.6% of total assets in 2025, up from 5.5% in 2021.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 63.0% of total assets, a decrease from 69.0% in 2021.
- Asset Diversification: The largest asset category is goodwill at 48.5% of total assets.
ESSILORLUXOTTICA 1/2/O.N. Competitors by Total Assets
Key competitors of ESSILORLUXOTTICA 1/2/O.N. based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Gan & Lee Pharmaceuticals Co Ltd
SHG:603087
|
China | CN¥12.68 Billion |
|
Andon Health Co Ltd
SHE:002432
|
China | CN¥29.91 Billion |
|
Shenyang Xingqi Pharmaceutical Co Ltd
SHE:300573
|
China | CN¥2.42 Billion |
|
Pegavision
TW:6491
|
Taiwan | NT$16.17 Billion |
|
Nanosonics Ltd
AU:NAN
|
Australia | AU$279.25 Million |
|
Visco Vision Inc.
TW:6782
|
Taiwan | NT$5.82 Billion |
|
QITIAN Technology Group Co Ltd
SHE:300061
|
China | CN¥1.17 Billion |
|
Embecta Corp
NASDAQ:EMBC
|
USA | $1.27 Billion |
ESSILORLUXOTTICA 1/2/O.N. - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.89 | 0.97 | 0.88 |
| Quick Ratio | 0.59 | 0.67 | 0.62 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | €-1.40 Billion | €-362.00 Million | €-1.31 Billion |
ESSILORLUXOTTICA 1/2/O.N. - Advanced Valuation Insights
This section examines the relationship between ESSILORLUXOTTICA 1/2/O.N.'s asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.73 |
| Latest Market Cap to Assets Ratio | 1.06 |
| Asset Growth Rate (YoY) | -0.6% |
| Total Assets | €63.90 Billion |
| Market Capitalization | $67.43 Billion USD |
Valuation Analysis
Above Book Valuation: The market values ESSILORLUXOTTICA 1/2/O.N.'s assets above their book value (1.06x), reflecting positive investor sentiment about the company's future prospects.
Slight Asset Contraction: ESSILORLUXOTTICA 1/2/O.N.'s assets decreased by 0.6% over the past year, which may reflect streamlining or optimization of resources.
Annual Total Assets for ESSILORLUXOTTICA 1/2/O.N. (2021–2025)
The table below shows the annual total assets of ESSILORLUXOTTICA 1/2/O.N. from 2021 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | €63.90 Billion ≈ $74.70 Billion |
-0.57% |
| 2024-12-31 | €64.26 Billion ≈ $75.13 Billion |
+6.18% |
| 2023-12-31 | €60.52 Billion ≈ $70.76 Billion |
-0.06% |
| 2022-12-31 | €60.56 Billion ≈ $70.80 Billion |
+1.93% |
| 2021-12-31 | €59.41 Billion ≈ $69.46 Billion |
-- |
About ESSILORLUXOTTICA 1/2/O.N.
EssilorLuxottica Société anonyme designs, manufactures, and distributes ophthalmic lenses, frames, sunglasses, and instruments and equipment in North America, the Middle East, Africa, Europe, Latin America, and the Asia-Pacific. It offers lens, eyewear, contact lenses, reading glasses under Essilor, Varilux, Crizal, Eyezen, Stellest, Xperio, Transitions, Ray-Ban, Oakley, Barberini, KODAK Lens, Ni… Read more